News Industry News Concept Medical Announces First Patient Enrollment in STARS DAPT Randomized Clinical Trial Evaluating Abluminus NP Polymer-Free DES January 16, 2026
News Conference News TCT 2025 At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I Yael L. Maxwell November 07, 2025
Presentation TCT 2025 TCT 468: Comparison of Limus and Paclitaxel Drug-Coated Balloons, 2nd-generation or Newer Drug-Eluting Stents, and Balloon Angioplasty: A Network Meta-Analysis of Randomized Controlled Trials Presenter: Yuko Kiyohara October 27, 2025
Presentation TCT 2025 TCT 511: Paclitaxel-Coated Balloons versus Newer-Generation Drug-Eluting Stents for De Novo Coronary Artery Lesions: A Meta-Analysis of Randomized Controlled Trials Presenter: Kamil Bujak October 27, 2025
Presentation TCT 2025 TCT 502: Drug-Coated Balloons Versus Drug-Eluting Stents for Patients with Diffuse De Novo Coronary Artery Lesions: Insights from the REC-CAGEFREE I Trial Presenter: Yuehao Lv October 27, 2025
Presentation TCT 2025 TCT 503: Impact of sex on outcomes in patients treated with drug-coated balloons versus drug-eluting stents for de novo coronary artery lesions: Insights from the REC-CAGEFREE I trial Presenter: Ping Wang October 27, 2025
Presentation TCT 2025 TCT 500: Clinical Outcomes of Patients With ST-Elevation Myocardial Infarction Treated With Drug-coated Balloons, Hybrid Strategies, or Drug-eluting Stents Presenter: Nancy Virginia October 27, 2025
News Conference News TCT 2025 Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION Michael O'Riordan October 26, 2025
Presentation TCT 2025 TCT 179: In-Stent Restenosis in Chronic Kidney Failure: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents Presenter: Rafal Adam Januszek October 26, 2025
Presentation TCT 2025 TCT 371: Drug-Coated Balloons Versus Drug-Eluting Stents for Side Branch Lesions in Coronary Bifurcations: A Systematic Review and Meta-Analysis Presenter: Fernando Manuel Quevedo October 26, 2025
Presentation TCT 2025 TCT 375: Optimizing Treatment for MEDINA 0.0.1 Bifurcation Lesions: A Comparative Evaluation of Drug-Coated Balloons and Drug-Eluting Stents Presenter: Sunwon Kim October 26, 2025
Presentation TCT 2025 TCT 174: A Comparative Analysis of Clinical Outcomes in Patients with In-Stent Restenosis Undergoing Percutaneous Coronary Intervention with Drug Coated Balloons and Drug Eluting Stents Presenter: Haseeb Ur Rahman October 26, 2025
News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Conference News ESC 2025 Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD L.A. McKeown September 05, 2025
News Daily News Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis L.A. McKeown August 12, 2025
News Industry News Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels June 12, 2025
News Conference News CRT 2025 AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years L.A. McKeown March 10, 2025
News Conference News VIVA 2024 Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK L.A. McKeown November 05, 2024
Presentation TCT 2024 A Hybrid Approach With Stents and Drug Coated Balloons: Mainstream or Niche? Presenter: Ricardo Costa October 30, 2024